Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Broccoli power: could cruciferous veggies stop bladder cancer return?

NCT ID NCT07391137

Disease control Sponsor: S. Andrea Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether eating a diet rich in cruciferous vegetables (like broccoli, cauliflower, and cabbage) can help prevent bladder cancer from coming back in people with intermediate to very high-risk non-muscle invasive bladder cancer. About 250 participants will either follow this special diet or continue their usual eating habits, alongside standard treatment. The main goal is to see if the vegetable-rich diet improves the chance of staying cancer-free for at least one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Histologically confirmed Non-Muscle Invasive Bladder Cancer of Intermediate, High, or Very High risk according to the 2021 EAU NMIBC scoring model. * Age ≥ 18 Exclusion Criteria: * Low-Risk Non-Muscle Invasive Bladder Cancer * Muscle Invasive Bladder Cancer * Life expectancy \< 5 years * WHO performance status 3 or 4 * Variant histology * Concomitant Urothelial Bladder Cancer in the Upper-Urinary Tract * Prostate or bladder radiotherapy * Urinary tract infection * Chronic urinary retention or indwelling catheters * Other ongoing oncological diseases * Active oncological treatments in the past 12 months * Persistent disease (defined as residual disease detected within three months after TURB or at first cystoscopy) * Specific dietary restrictions such as a vegetarian diet, celiac disease, or lactose intolerance * Chronic Kidney Disease * Chronic inflammatory diseases such as Crohn's disease or ulcerative colitis * History of gastric resection * Hepatic disorders such as cirrhosis or ALT/AST levels three times above the upper normal limit * Thyroid disorders * Warfarin therapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder cancer recurrence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms Recurrence Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder cancer recurrence Recurrence free survival

Contacts and locations

Locations

  • S.Andrea Hospital of Rome

    Rome, Lazio, 00135, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.